ASO作者反思：转化治疗后不可切除肝细胞癌挽救性手术的影响：是否应推荐？ - Suppr

ASO Author Reflections: Impact of Salvage Surgery in Unresectable Hepatocellular Carcinoma After Conversion Therapy: Should it be Recommended?

作者信息

Wu Jun-Yi, Wu Jia-Yi, Fu Yang-Kai, Yan Mao-Lin

机构信息

Department of Hepatobiliary Pancreatic Surgery, The Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China.

Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, China.

出版信息

Ann Surg Oncol. 2024 May;31(5):3100-3101. doi: 10.1245/s10434-024-14991-w. Epub 2024 Feb 1.

DOI:10.1245/s10434-024-14991-w

PMID:38300403

Abstract

摘要

相似文献

ASO Author Reflections: Impact of Salvage Surgery in Unresectable Hepatocellular Carcinoma After Conversion Therapy: Should it be Recommended?ASO作者反思：转化治疗后不可切除肝细胞癌挽救性手术的影响：是否应推荐？

Ann Surg Oncol. 2024 May;31(5):3100-3101. doi: 10.1245/s10434-024-14991-w. Epub 2024 Feb 1.

ASO Author Reflections: Hepatectomy for Multiple Hepatocellular Carcinomas.ASO作者反思：多发性肝细胞癌的肝切除术

Ann Surg Oncol. 2022 Dec;29(13):8446-8447. doi: 10.1245/s10434-022-12507-y. Epub 2022 Sep 5.

ASO Author Reflections: Preoperative Hypercoagulability Predicts Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Hepatectomy.ASO作者反思：术前高凝状态预示肝切除术后微血管侵犯的肝细胞癌患者预后不良。

Ann Surg Oncol. 2019 Dec;26(Suppl 3):806-807. doi: 10.1245/s10434-019-07986-5. Epub 2019 Oct 25.

ASO Author Reflections: Resection for Hepatocellular Carcinoma Beyond the BCLC Guidelines-How Can Machine Learning Techniques Help?ASO作者反思：超出BCLC指南的肝细胞癌切除术——机器学习技术如何提供帮助？

Ann Surg Oncol. 2020 Mar;27(3):875-876. doi: 10.1245/s10434-019-08036-w. Epub 2019 Nov 4.

ASO Author Reflections: Pre-transplant Treatments for Patients with Hepatocellular Carcinoma Before Liver Transplantation.ASO作者反思：肝细胞癌患者肝移植前的移植前治疗

Ann Surg Oncol. 2023 Mar;30(3):1420-1421. doi: 10.1245/s10434-022-12964-5. Epub 2023 Jan 13.

ASO Author Reflections: Laparoscopic Right Posterior Sectionectomy with Preservation of Subsegment Using Digital Intelligence Liver Surgery Technologies in Patients with HCC After Conversion Therapy.ASO作者反思：在接受转化治疗后的肝癌患者中，使用数字智能肝脏手术技术进行保留亚段的腹腔镜右后段切除术

Ann Surg Oncol. 2024 Sep;31(9):5655-5657. doi: 10.1245/s10434-024-15612-2. Epub 2024 Jun 13.

ASO Author Reflections: Recurrence Patterns and Outcomes After Resection of Hepatocellular Carcinoma Within and Beyond the Barcelona Clinic Liver Cancer Criteria.ASO作者反思：巴塞罗那临床肝癌标准范围内外肝细胞癌切除术后的复发模式与结局

Ann Surg Oncol. 2020 Jul;27(7):2332-2333. doi: 10.1245/s10434-020-08455-0. Epub 2020 Apr 15.

ASO Author Reflections: The Prognostic Value of Preoperative Serum Markers and Risk Classification of Patients With Hepatocellular Carcinoma.ASO作者反思：术前血清标志物对肝细胞癌患者的预后价值及风险分类

Ann Surg Oncol. 2023 May;30(5):2816-2817. doi: 10.1245/s10434-022-13063-1. Epub 2023 Feb 3.

ASO Author Reflections: An Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for Patients with Hepatocellular Carcinoma.ASO作者反思：一种用于预测肝细胞癌患者术前微血管侵犯风险的在线计算器。

Ann Surg Oncol. 2023 Feb;30(2):734-735. doi: 10.1245/s10434-022-12498-w. Epub 2022 Sep 4.

ASO Author Reflections: Impact of Surgical Margin Width on Prognosis After Resection of Hepatocellular Carcinoma Varies Based on Preoperative Alpha-Feto Protein and Tumor Burden Score.ASO作者反思：手术切缘宽度对肝细胞癌切除术后预后的影响因术前甲胎蛋白和肿瘤负荷评分而异。

Ann Surg Oncol. 2023 Oct;30(11):6590-6591. doi: 10.1245/s10434-023-13918-1. Epub 2023 Jul 17.

本文引用的文献

ASO Author Reflections: Large Language Models Offer Substantial Potential for Specialized Applications in the Medical Field.ASO作者反思：大语言模型在医学领域的专业应用具有巨大潜力。

Ann Surg Oncol. 2024 Jun;31(6):3912-3913. doi: 10.1245/s10434-024-15226-8. Epub 2024 Mar 28.

Outcomes of Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma Converted by Transcatheter Arterial Chemoembolization Combined with Lenvatinib plus Anti-PD-1 Antibodies: A Multicenter Retrospective Study.经动脉化疗栓塞联合乐伐替尼加抗程序性死亡蛋白1抗体转化后进行挽救性手术治疗初始不可切除肝细胞癌的疗效：一项多中心回顾性研究

Liver Cancer. 2022 Nov 30;12(3):229-237. doi: 10.1159/000528356. eCollection 2023 Aug.

Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors.使用乐伐替尼、经动脉化疗栓塞术（TACE）联合PD-1抑制剂进行转化治疗的初治不可切除肝细胞癌的疗效及预后因素

Front Oncol. 2023 Jan 30;13:1110689. doi: 10.3389/fonc.2023.1110689. eCollection 2023.

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma.酪氨酸激酶抑制剂联合抗 PD-1 抗体治疗后行肝切除术治疗不可切除肝细胞癌患者。

Ann Surg Oncol. 2023 May;30(5):2782-2790. doi: 10.1245/s10434-022-12530-z. Epub 2022 Sep 30.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Impact of Salvage Surgery in Unresectable Hepatocellular Carcinoma After Conversion Therapy: Should it be Recommended?

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

本文引用的文献